Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jan 22.
Published in final edited form as: Organometallics. 2012 Oct 8;31(19):6843–6850. doi: 10.1021/om300671j

Mechanistic Studies of Azaphilic versus Carbophilic Activation by Gold(I) in the Gold/Palladium Dual-Catalyzed Rearrangement of Alkenyl Vinyl Aziridines

Joshua J Hirner 1,, Katrina E Roth 1,, Yili Shi 1, Suzanne A Blum 1,*
PMCID: PMC3898857  NIHMSID: NIHMS408715  PMID: 24465074

Abstract

A vinyl aziridine activation strategy cocatalyzed by palladium(0) and a gold(I) Lewis acid has been developed. This rearrangement installs a C–C and a C–N bond in one synthetic step to form pyrrolizidine and indolizidine products. Two proposed mechanistic roles for the gold cocatalyst were considered: (1) carbophilic gold catalysis or (2) azaphilic gold catalysis. Mechanistic studies support an azaphilic Lewis acid activation of the aziridine over a carbophilic Lewis acid activation of the alkene.

Introduction

Recent years have witnessed substantial progress in the development of a variety of dual-catalyzed reactions as a strategy to access unique reactivity and selectivity. However, significantly less is known about designing dual-catalyzed reactions as compared to their singly catalyzed counterparts,114 especially about strategies for avoiding potentially undesired redox reactions between the catalysts that may quench their catalytic activity.8b Among these dual-catalytic reactions, there are several classes of distinct catalyst pairs: metal-metal,18 metal-metalloid, 9,10 metal-organocatalyst,1113 and organocatalyst-organocatalyst.14 Our approach for developing dual-metal-catalyzed reactions aims to combine the well-established Lewis acidic activity of Au(I)1517 with a Lewis basic transition metal catalyst.18 We have previously demonstrated that combining the distinct reactivities of Au(I) and Pd(0) catalysts allows for new reactivity unavailable to single-metal systems.3,4,19 Herein, we describe a new Au(I) and Pd(0) dual-catalytic system for the rearrangement of alkene-tethered vinyl aziridines and provide insight into the mechanism of this dual-catalytic system.

We were inspired by recent reports of gold-catalyzed hydroamination reactions of olefins, which are proposed to proceed through carbophilic activation leading to alkylgold intermediates (Scheme 1a).20 Toste and coworkers have supported the elementary step of carbophilic activation through the isolation of alkylgold intermediates in a gold-promoted hydroamination reaction.21 In Au-catalyzed hydroamination reactions, this C–Au σ-bond is often proposed to undergo subsequent protodeauration to form a C–H bond; however, the exact role of the Lewis acidic metal is a subject of ongoing investigation.22

Scheme 1.

Scheme 1

(a) Illustrative example of proposed carbophilic hydroamination work by others. (b) This work: original envisioned analogous mechanism for carbophilic carboamination.

Mechanistically related to the hydroamination reaction, we envisioned a carboamination reaction23 (Scheme 1b). We hypothesized that vinyl aziridine 1 could undergo a carbophilic gold-catalyzed cyclization similar to Toste’s aminoauration of olefins with ureas21 and Bertrand’s aminoauration of alkynes with tertiary amines (Scheme 1a).24 The resulting vinyl aziridinium 3 would be electronically activated for oxidative addition by Pd(0) because of the enhanced leaving group ability of the ammonium.25 An intramolecular gold/palladium cross-coupling reaction would afford pyrrolizidine 2 and regenerate both gold and palladium catalysts.

Herein, we report a Pd and Lewis acid cocatalyzed rearrangement of vinyl aziridines to form pyrrolizidine and indolizidine frameworks. These two classes of N-fused heterocycles are of interest because of their biological activity.2629 Subsequent mechanistic experiments revealed that the mechanism analogous to hydroamination shown in Scheme 1 was not operative in the carboamination transformation; instead, the reaction proceeds through an azaphilic activation pathway, which is uncommon for Au(I).3032

Results and Discussion

To probe the conceptualized carboamination reactivity, we treated gem-diphenyl vinyl aziridine 1a with 5 mol % (CAAC)AuCl/NaBArF and 2.5 mol % Pd2dba3 in CD2Cl2 at room temperature (Table 1). This reaction afforded carboamination product pyrrolizidine 2a in 76% isolated yield. This reaction tolerated adamantyl (2b, 86%), cyclohexyl (2c, 56%), and cyclopentyl (2d, 51%) substitutions. However, a gem-dimethyl group substitution (1f) gave no reaction, presumably due to a reduced rate of cyclization from a diminished Thorpe-Ingold effect.33 Methyl substitution at the internal position of the tethered alkene was tolerated (2e, 67%). Increasing the olefin tether length in diphenyl vinyl aziridine 1g afforded indolizidine 2g in good yield (74%) with an increased diastereomeric ratio (10:1).

Table 1.

Substrate scope of the dual-catalyzed carboamination reaction.

graphic file with name nihms408715t1.jpg
Starting material Product Isolated Yield d.r.
graphic file with name nihms408715t2.jpg graphic file with name nihms408715t3.jpg 76% 1:1
graphic file with name nihms408715t4.jpg graphic file with name nihms408715t5.jpg 86%a 1:1
graphic file with name nihms408715t6.jpg graphic file with name nihms408715t7.jpg 56%b 3:1
graphic file with name nihms408715t8.jpg graphic file with name nihms408715t9.jpg 51%c,d 4:1
graphic file with name nihms408715t10.jpg graphic file with name nihms408715t11.jpg 67%b,c 2:1
graphic file with name nihms408715t12.jpg graphic file with name nihms408715t13.jpg NRc -
graphic file with name nihms408715t14.jpg graphic file with name nihms408715t15.jpg 74%d 10:1
a

15 mol % (CAAC)AuCl/NaBArF, 7.5 mol % Pd2dba3, 5 d.

b

48 h.

c

10 mol % (CAAC)AuCl/NaBArF, 5 mol % Pd2dba3.

d

40 °C.

Control experiments revealed that both Pd2dba3 and in situ-generated (CAAC)AuBArF were required for the observed dual-catalytic reactivity (Table 2). In contrast to our previous reports of Pd/Au cocatalyzed reactions,3,4 however, this reaction displayed a slow but nonzero background reaction with Pd2dba3 alone.

Table 2.

Control experiments.

Catalyst(s) Loading Time Conversiona
(CAAC)AuCl/NaBArF (7/8) 5.0 mol % / 5.0 mol % 15 h No reaction
CAAC carbene/Pd2dba3 10. mol % / 5.0 mol % 16 h No reaction
PdCl2(PPh3)2/AgSbF6 10. mol % / 20. mol % 16 h Decomposition
Pd2dba3 5.0 mol % 15 h 7 %
NaBArF (8) 5.0 mol % 16 h No reaction
CAAC carbene 10. mol % 16 h No reaction
a

By 1H NMR spectroscopy.

In order to probe the mechanism of this reaction, Z and E monodeuterated analogs of vinyl aziridine 1a were subjected to the dual-catalytic rearrangement conditions (eqs 2 and 3). The Z diastereomer (1a') generated only the 1,2-trans product 2a', and the E diastereomer of aziridine (1a'') provided exclusively the 1,2-cis diastereomer 2a''.

graphic file with name nihms408715f6.jpg (2)
graphic file with name nihms408715f7.jpg (3)

This observed stereospecificity was inconsistent with a carbophilic activation mechanism (Scheme 1b), which would have resulted in the opposite diastereomer of each product at the deuterium-labeled carbon. In a carbophilic activation mechanism, the cationic gold catalyst could bind reversibly to the tethered olefin34 and serve as a carbophilic Lewis acid (Scheme 2, complex 9). The aziridine would then be primed for an intramolecular anti aminoauration to provide 10,35 an elementary step well-established for other amine nucleophiles with both Au(I)20a,21 and Au(III).36 Pd(0) could then undergo oxidative addition into the aziridinium moiety, and alkyl Au- to- Pd alkyl transmetalation37 with retention of configuration (Pathway A) would provide palladacycle 11. A stereochemically retentive transmetalation, which is typical for with Pd(II) with relatively nonpolar organometallic complexes such as trialkyl-38 and pinacol-boronates39 and alkyl mercury(II) complexes,40 is expected due to the nonpolar nature of the C–Au bond.41 A retentive C–C bond-forming reductive elimination42 from Pd(II) intermediate 11 would have provided the expected 1,2-cis product 2a'. Instead, 1,2-trans pyrrolizidine product 2a'' was formed exclusively, thus eliminating Pathway A from further consideration.

Scheme 2.

Scheme 2

Possible mechanistic pathways explaining the stereochemical course of the reaction.

This surprising mechanistic data inspired us to consider several alternative mechanisms (Scheme 2). First, Pd(0) could undergo oxidative addition into the aziridinium complex 10 but instead undergo an invertive transmetalation reaction (Pathway B). However, invertive transmetalation reactions generally occur only for polarized carbon–metal bonds,43 such as alkyl lithium44 and alkyl trifluoroborate45 compounds or in highly polar solvents, such as HMPA.46,47 In contrast, the C–Au bond is largely nonpolar,41 and the dichloromethane used in our reactions is a less polar solvent; an invertive transmetalation from an alkyl-Au complex would thus represent an unusual elementary step. Pathway B was therefore unlikely, but further investigation into the stereochemistry of this fundamental step was warranted (vida infra).

We considered another possible mechanism in which the cationic gold complex bound reversibly to the aziridine nitrogen as an azaphilic Lewis acid3032 (complex 9b), priming the vinyl aziridine for oxidative addition by Pd(0)48 to provide heterobimetallic amide 13. Intermediate 13 is then poised for a syn aminoauration reaction (Pathway C), a selectivity postulated only very infrequently.4952 The alkyl-Au fragment in 14 could then undergo a retentive transmetalation, which is expected based upon the polarity of the C–Au bond. Finally, retentive reductive elimination from palladacycle 12 would provide the observed diastereomer of pyrrolizidine product 2a''. The dearth of evidence supporting syn aminoauration by Au(I) in contrast to the abundance of data supporting anti aminoauration by Au(I)20a,21 makes this mechanistic hypothesis less likely; however, this pathway cannot be disregarded.

A final possible mechanism was considered in which the Pd intermediate 15 undergoes a syn aminopalladation53,54 reaction with the tethered olefin to provide 12 directly (Pathway D). This mechanistic hypothesis circumvents the unlikely syn aminoauration step and avoids the stereochemical complexities associated with the alkyl Au-to-Pd transmetalation reaction. Pathway D bears a mechanistic resemblance to the Pd-only-catalyzed aminoarylations of olefins pioneered by Wolfe, which have been shown to proceed through syn aminopalladation elementary steps.55

In order to further differentiate between the four proposed mechanisms, we attempted to characterize several of the organometallic intermediates shown in Scheme 2, but these attempts were ultimately unfruitful. Attention was instead turned towards probing the stereochemical outcome of the possible Au-to-Pd alkyl transmetalation step. We prepared alkylgold complex 16 (Figure 1a), which was recently isolated by Toste in a gold-promoted mechanistic study of the aminoauration of olefins.21 We envisioned that this isolable complex could model the reactivity of possible catalytic intermediate 10 (Scheme 2, Pathways A and B) with Pd: both complexes possess an alkyl-Au fragment exocyclic to a pyrrolidine core. Furthermore, both also possess a tethered Lewis basic group (Figure 1a, highlighted in blue), which could serve as a directing group for transmetalation by first binding to Pd.

Figure 1.

Figure 1

(a) A possible catalytic intermediate (10) and its isolable model complex (16). (b) Stoichiometric alkyl transmetalation from Au to Pd showing complete retention of stereochemistry.

We treated model alkylgold complex 16 with a source of dicationic Pd and 2,2'-bipyridine. The sole pyrrolidine product was characterized spectroscopically as 17 via an nOe experiment. Specifically, irradiating at the indicated proton in complex 17 resulted in an nOe enhancement at the alkyl-Pd chiral center (Fig. 1b). Molecular modeling using density functional theory (DFT) calculations using the PBE functional56 on the analogous perprotiated complex (Figure 2) confirm the urea binding mode shown in Figure 1b. This first example of a direct observation of the stereochemical outcome of a transmetalation of chiral sp3 organogold to Pd indicates that the transmetalation from Au complex 16 occurs with complete retention of stereochemistry. Given the nOe data and the several prior reports of retentive transmetalation with other nonpolar organometallic compounds,3840 mechanistic Pathway B (Scheme 2) was eliminated from further consideration. Thus, both carbophilic activation mechanisms A and B were ruled out on the basis of the experimental data.

Figure 2.

Figure 2

Calculated structure of perprotiated 17 with counterion and aromatic protons omitted for clarity.

With Pathways A and B eliminated from consideration in favor of azaphilic pathways C and D, we then sought to understand more about the nature of the active azaphilic Au(I) cocatalyst. The reaction of (CAAC)AuCl (7) with NaBArF (8) rapidly and quantitatively affords (CAAC)AuBArF and NaCl; however, it is possible that NaBArF was present in equilibrium57 with (CAAC)AuBArF/NaCl and cocatalyzed the reaction. Indeed, even in the absence of Au(I), NaBArF was a competent cocatalyst with Pd(0), promoting the reaction in 87% 1H NMR spectroscopic yield (Table 3, entry 1). This assay yield is higher than that which was obtained in the presence of (CAAC)AuBArF/NaCl (entry 2), yet rigorous removal of NaCl from (CAAC)AuBArF confirmed that (CAAC)AuBArF was a competent cocatalyst in the absence of Na (entry 3). 58

Table 3.

Investigation into the active Lewis acid cocatalyst from Table 1

graphic file with name nihms408715t16.jpg
Entry Lewis Acid 1H NMR Yielda
1 NaBArF (8) 87%
2 (CAAC)AuBArF generated in situ from 7+8, NaCl not removed 79%
3 (CAAC)AuBArF pre-formed from 7+8, NaCl removed 64%
4 (NBu4)BArF 27%
5 None 18%
a

Relative to mesitylene internal standard. Reaction conditions: 1a (1.0 equiv), Pd2dba3 (2.5 mol%), Lewis acid (5.0 mol%), CD2Cl2, 25 °C, 24 h.

In order to separate the effects of the Na cation from the BArF anion, (NBu4)BArF was examined as a cocatalyst with Pd(0) (entry 6). Its poor cocatalytic activity confirms the hypothesis that the azaphilic Lewis acid Na+ is indeed responsible for the observed reactivity from NaBArF rather than any significant ion exchange effects from the BArF anion itself, in contrast to that reported for a previous π-allyl palladium coupling.59

We suspected that the same azaphilic activation mechanism may be operative for both (CAAC)AuBArF and NaBArF. To test this hypothesis, we repeated the rearrangement of deuterium-labeled aziridine 1a' (eq 2) after rigorously removing NaCl from (CAAC)AuBArF. The 1,2-trans product 2a' was again obtained, albeit with a longer reaction time (perhaps due to catalyst loss upon filtration); the stereochemical course of the reaction is thus the same for the Au(I) Lewis acid and the mixture of Au(I) and Na, suggesting that Na and Au(I) Lewis acids operate by a similar azaphilic activation pathway. Therefore, the mechanism of this reaction represents an uncommon reaction manifold for Au(I), which is generally employed as a carbophilic Lewis acid.1517 We have further supported the plausibility of this Au–N binding mode in the presence of a tethered olefin by DFT calculations, which revealed that the binding of a model (NHC)Au(I) cation to vinyl aziridine 1f favored the N-bound complex30 over the π-complex by nearly 17 kcal/mol (eq 4). Of course, these data do not preclude the possibility of a Curtin-Hammett-type reaction manifold in which the thermodynamically disfavored π-complex (19) is the kinetically competent intermediate; however, they do demonstrate the feasibility of Au(I) binding to the aziridine as originally established crystallographically by Nöh and coworkers,30 and that this Nöh-type binding remains theromodynamically accessible even in the presence of a potentially competing olefin.

graphic file with name nihms408715f8.jpg (4)

Based on the mechanistic data and the efficacy of the NaBArF Lewis acid as a cocatalyst, we propose the catalytic cycle shown in Scheme 3. First, the aziridine undergoes Lewis acid-promoted oxidative addition910 by Pd(0). The resulting Pd(II) intermediate 20 then undergoes a syn aminometalation.60 The observed product 2 is then obtained following a reductive elimination from palladacyclic intermediate 21. This catalytic cycle is generalized from mechanistic Pathways C or D from Scheme 2.

Scheme 3.

Scheme 3

General catalytic cycle.

Conclusions

In conclusion, we have demonstrated a Pd and Lewis acid dual-catalyzed rearrangement of vinyl aziridines to pyrrolizidine and indolizidine products. This reaction installs a new C–C bond and a new C–N bond in N-fused heterocyclic frameworks in one synthetic step. During the course of mechanistic experiments, an alkyl Au/Pd transmetalation was found to occur with complete retention of stereochemistry. This first study of the retentive stereochemistry of transmetalation of chiral organogold(I) complexes to palladium and a successful strategy for avoiding competing redox quenching of gold(I) by palladium provide insight into this subset of dual-metal catalysis.8b,18

The reaction was found not to proceed through carbophilic Au(I) catalysis. Instead, an uncommon role for catalytic Au(I) as an azaphilic Lewis acid was revealed, even in the presence of a potential competing carbophilic activation pathway. These mechanistic studies lend support to previous reports that gold binding to heteroatoms may be responsible for catalytic activity in some gold-catalyzed hydroamination reactions of alkenes, rather than direct gold π-complex activation. 22a–c

Experimental

General information

All chemicals were used as received from commercial sources unless otherwise noted. Acetonitrile, dichloromethane, diethyl ether, methanol, and tetrahydrofuran were dried by passage through an alumina column under argon pressure on a push-still solvent system. Dichloromethane-d2 was dried over CaH2, degassed using three freeze-pump-thaw cycles, and vacuum transferred prior to use. N,N-Diisopropyl ethyl amine (DIPEA) was distilled under nitrogen before use. Aziridines 1ag were prepared as described in the electronic Supplementary Information. (CAAC)AuCl61 (5) and NaBArF62 (6) were prepared according to literature procedures. [Pd(MeCN)4][BF4]2 was purchased from Sigma-Aldrich. All manipulations were conducted in a glovebox under nitrogen atmosphere or using standard Schlenk techniques unless otherwise specified. Analytical TLC was performed on Dynamic Absorbents 250 µm TLC plates with F-254 indicator. Plates were visualized under UV irradiation (254 nm), and/or using an aqueous solution of KMnO4 or an ethanol solution of ninhydrin followed by heating. Flash chromatography was conducted using Grace Davisil 35–70 µm silica gel or Acros 50–200 µm basic aluminum oxide (activity I). All proton and carbon nuclear magnetic resonance (1H and 13C NMR) spectra were recorded on a Bruker DRX-500 spectrometer, a Bruker DRX-500 spectrometer outfitted with a cryoprobe, or a Bruker AVANCE600 spectrometer. All chemical shifts are reported in parts per million. 1H and 13C NMR spectroscopy experiments are calibrated to the residual proteosolvent resonance. Low and high-resolution mass spectrometry data were obtained at a facility operated by the University of California, Irvine.

Diphenyl pyrrolizidine 2a

In the glovebox, gold precatalyst 7 (3.0 mg, 0.020 mmol, 5.0 mol %), NaBArF salt 8 (4.4 mg, 0.020 mmol, 5.0 mol %), Pd2dba3 (2.3 mg, 0.010 mmol, 2.5 mol %), and aziridine 1a (28.9 mg, 0.100 mmol, 1.00 equiv) were weighed into separate dram vials. Dry DCM (1.0 mL) was added via syringe to the dram vial containing (CAAC)AuCl and this solution was then added to the dram vial containing NaBArF. The (CAAC)AuCl/NaBArF solution was added to the dram vial containing aziridine 1a. To the dram vial containing Pd2dba3 was added the solution containing substrate, (CAAC)AuCl, and NaBArF in DCM. The dram vial was capped and allowed to stir for 24 h. The reaction was then taken out of the glovebox and purified by silica gel chromatography eluting using a gradient from 1:0:100 to 1:5:95 NH4OH:MeOH:CHCl3 to give 2a as a white solid (22 mg, 76% yield, 1.0:1.0 d.r.). The isolation procedure did not alter the product d.r., which was detected as 1:1 by 1H NMR spectroscopy in a separate reaction run in CD2Cl2 on 0.050 mmol scale. 1H NMR (CDCl3, 500 MHz): δ 1.43–1.51 (m, 1H), 1.82–1.86 (m, 2H), 2.11 (dd, J = 11.9, 10.6 Hz, 1H), 2.19–2.23 (m, 2H), 2.42 (dd, J = 11.1, 10.2 Hz, 1H), 2.71–2.75 (m, 2H), 2.78–2.94 (m, 3H), 2.98 (dd, J = 9.7, 3.5 Hz, 2H), 3.07–3.17 (m, 1 H), 3.38 (dd, J = 8.6, 6.1 Hz, 1H), 3.61–3.72 (m, 2H), 4.11–4.18 (m, 2H), 4.99–5.08 (m, 2H), 5.14 (app d, J = 17.4 Hz, 2H), 5.76–5.90 (m, 2H), 7.17–7.38 (m, 16 H), 7.44–7.52 (m, 4H). 13C NMR (CDCl3, 125 MHz): δ 38.4, 39.3, 40.6, 45.2, 48.0, 55.9, 59.6, 60.8, 61.8, 62.9, 64.0, 66.2, 66.7, 114.6, 114.8, 126.0, 126.2, 126.6, 126.7, 126.9, 127.0, 128.1, 128.32, 128.34, 128.4, 139.2, 139.4, 146.3, 146.7, 147.4, 147.6. HRMS (ESI+): [M+H]+ calcd for C21H24N, 290.1909; found, 290.1911.

Adamantyl pyrrolizidine 2b

In the glovebox, gold precatalyst 7 (6.3 mg, 0.010 mmol, 15 mol %) was dissolved in 0.3 mL dry DCM and added to a dram vial containing NaBArF salt 8 (9.2 mg, 0.010 mmol, 15 mol %). The resulting suspension was added to a screw-cap dram vial containing aziridine 1b (18 mg, 0.069 mmol, 1.0 equiv). A single 0.3 mL portion of DCM was used to rinse the two vials formerly containing the gold precatalyst and the NaBArF salt to aid in complete transfer to the aziridine vial. Finally, Pd2dba3 (4.8 mg, 0.0052 mmol, 7.5 mol %) was added to the aziridine mixture as a solution in 0.3 mL DCM. The reaction vessel was capped and stirred at 25 °C in the glovebox 5 d. The crude reaction mixture was then removed from the glovebox and concentrated in vacuo. The mixture was purified using a silica gel pipet column eluting using a gradient 1:0:99 to 1:5:94 NH4OH:MeOH:CHCl3. The product was obtained as a mixture of diastereomers (16 mg, 88% yield, d.r. = 1.0 : 1.0). Diastereomer A. 1H NMR (CDCl3, 500 MHz): δ 1.69–1.99 (m, 14 H), 2.06 (dd, J = 13.0, 6.6 Hz), 2.59–2.64 (m, 1H), 2.85 (J = 14.0, 7.3 Hz, 1H), 3.20–3.26 (m, 1H), 3.29 (d, J = 13.9 Hz, 1H), 3.81 (t, J = 10.0 Hz, 1H), 4.02 (dd, J = 12.1, 6.7 Hz, 1H), 4.84 (d, J = 13.7 Hz, 1H), 5.03 (q, J = 9.4 Hz, 1H), 5.22 (d, J = 10.3 Hz, 1H), 5.28 (d, J = 17.2 Hz, 1H), 5.78–5.88 (m, 2H). Diastereomer B. 1.69–1.99 (m, 14 H), 2.12 (dd, J = 13.8, 6.5 Hz, 1H), 2.57 (d, J = 8.4 Hz, 1H), ca. 2.79 (dd, 1H), c.a. 3.31 (1H), 3.54–5.63 (m, 1H), 3.85 (d, J = 13.6 Hz, 1H), 4.06 (d, J = 13.4 Hz, 1H), 4.63 (dd, J = 12.9, 8.1 Hz, 1H), 5.08 –5.14 (m, 1H), 5.17–5.25 (m, 2H), 5.70 (d, J = 9.8 Hz, 1H), 6.16 (d, J = 9.9 Hz, 1H). 13C NMR (CDCl3, 125 MHz): 26.8, 26.9, 33.4, 33.4, 33.7, 35.0, 37.0, 39.4, 40.0, 42.6, 49.3, 68.4, 70.6, 72.4, 76.7, 119.3, 133.3. Note: Not all signals were observable. HRMS (GC/EI+): [M]+ calcd for C18H27N, 257.2144; found, 257.2137.

Cyclohexyl spirocyclic pyrrolizidine 2c

In the glovebox, gold precatalyst 7 (6.7 mg, 0.011 mmol, 5.0 mol %) was dissolved in 0.3 mL dry DCM and added to a dram vial containing NaBArF salt 8 (9.7 mg, 0.011 mmol, 5.0 mol %). Two 0.3 mL portions of DCM were used as a rinse to ensure full transfer of the gold precatalyst to the NaBArF vial. The resulting suspension was added to a screw-cap dram vial containing aziridine 1c (45 mg, 0.22 mmol, 1.0 equiv). Three 0.3 mL portions of DCM were used as a rinse to ensure full transfer of the (CAAC)AuCl/NaBArF suspension. Finally, Pd2dba3 (5.0 mg, 0.0055 mmol, 2.5 mol %) was added to the aziridine mixture as a solution in 0.3 mL DCM. Two 0.35 mL portions of DCM were used as a rinse to ensure full transfer of the Pd solution. The reaction vessel was capped and stirred at 25 °C in the glovebox for 48 h. The crude reaction mixture was then removed from the glovebox and concentrated in vacuo. The mixture was purified twice: once using a silica gel pipet column eluting from 1:5:94 NH4OH:MeOH:CHCl3 and then once using preparatory TLC developed using 1:10:89 NH4OH:MeOH:CHCl3. The product was obtained as a mixture of diastereomers (25 mg, 56% yield, d.r. = 2.6 : 1.0). Analytical purity was confirmed using GC/MS. Major diastereomer, 1H NMR (CDCl3, 500 MHz): δ 1.26–1.98 (m, 10H), 2.06 (dd, J = 13.5, 6.0 Hz, 1H), 2.49–2.61 (m, 2H), 3.18–3.27 (m, 1H), 3.34 (d, J = 13.5 Hz), 3.78 (t, J = 12.0 Hz, 1H), 4.09 (dd, J = 12.2, 7.0 Hz, 1H), 4.44 (d, J =13.5, 1H), 5.01–5.06 (m, 1H), 5.21–5.27 (m, 2H), 5.78–5.81 (m, 2H), 6.01 (d, J = 10.0 Hz, 1H). Minor diastereomer, 1H NMR (CDCl3, 500 MHz): δ 1.26–1.98 (m, 10H), c.a. 2.06 (1H), 2.12 (d, J = 7.4 Hz, 1H), 2.45–2.49 (m, 1H), 2.76–2.83 (m, 1H), 3.53–3.58 (m, 1H), 3.69 (d, J = 13.1 Hz, 1H), 3.88 (d, J = 13.0 Hz, 1H), 4.66 (dd, J = 12.5, 7.4 Hz), 5.11–5.14 (m, 2H), 5.71–5.81 (m, 2H), 6.17 (d, J = 10.1 Hz). Note: The signal near 2.06 ppm is entirely obfuscated by the major diastereomer and was detected implicitly by over-integration of the peak. 13C NMR (CDCl3, 125 MHz): 22.6, 23.1, 23.4, 23.6, 25.1, 25.3, 36.9, 36.9, 37.2, 37.4, 38.4, 40.1, 41.3, 43.6, 44.6, 67.5, 68.7, 68.9, 70.8, 74.5, 118.6, 119.2, 133.2, 134.9. Note: the signal at 74.5 ppm was only observable in an HMQC spectrum through its coupling to the corresponding ipso protons. Not all signals arising from the minor diastereomer were observable. HRMS (GC/EI+): [M]+ calcd for C14H23N, 205.1830; found, 205.1835. The relative stereochemistry of the major diastereomer of 2c was determined through comparison of the 1H NMR chemical shifts to the major diastereomer of 2d.

Cyclopentyl spirocyclic pyrrolizidine 2d

In the glovebox, gold precatalyst 7 (9.2 mg, 0.015 mmol, 10. mol %) was dissolved in 0.3 mL dry DCM and added to a dram vial containing NaBArF salt 8 (13.3 mg, 0.0150 mmol, 10.0 mol %). Next, 0.3 mL of DCM was used as a rinse to ensure full transfer of the gold precatalyst to the NaBArF vial. The resulting suspension was added to a screw-cap dram vial containing aziridine 1d (29.0 mg, 0.150 mmol, 1.00 equiv). Then, 0.3 mL of DCM was used as a rinse to ensure full transfer of the (CAAC)AuCl/NaBArF suspension. The resulting solution was added to a screw-cap dram vial containing Pd2dba3 (6.9 mg, 0.0075 mmol, 5.0 mol %). Then, 0.3 mL of DCM was used as a rinse to ensure full transfer of the Pd solution. The solution was transferred to a J. Young tube and 0.3 mL of DCM was used as a rinse to ensure full transfer of the solution. The solution was heated in the J. Young tube at 40 °C for 24 h. The crude reaction mixture was then concentrated in vacuo. The mixture was purified twice: once using a silica gel pipet column eluting with 0.1:1:10 NH4OH:MeOH:CHCl3 and then once using a silica gel pipet column eluting with 0.1:1:10 NH4OH:MeOH:CH2Cl2. The product was obtained as a mixture of diastereomers (14.7 mg, 51mol % d.r. = 4.4 : 1.0). The product was isolated with an inseparable 16% NH4OH impurity. Major diastereomer. 1H NMR (CD2Cl2, 500 MHz): δ 1.59–2.02 (m, 10H), 2.40 (dd, J = 13.0, 7.9 Hz, 1H), 2.59–2.66 (m, 1H), 3.19–3.26 (m, 1H), 3.46 (d, J = 13.0 Hz, 1H), 3.75 (t, J = 12.2 Hz, 1H), 3.90 (dd, J = 12.1, 6.5 Hz, 1H), 4.31 (d, J =12.9, 1H), 4.81–4.87 (m, 1H), 5.21–5.25 (m, 1H), 5.27–5.32 (m, 1H), 5.82 (ddd, J = 17.2, 10.1, 7.4 Hz, 1H). 13C NMR (CD2Cl2, 125 MHz): δ 23.6, 25.3, 36.6, 36.7, 37.2, 40.3, 44.8, 49.6, 67.4, 73.0, 78.4, 118.8, 133.3. Minor diastereomer. 1H NMR (CD2Cl2, 500 MHz): δ 1.59–1.98 (m, 10H), 2.56 (d, J = 13.4, 8.4 Hz, 1H), 2.69–2.75 (m, 1H), 3.33 (t, J = 12.3 Hz, 1H), c.a. 3.50 (m, 1H), 3.66 (d, J = 12.7 Hz, 1H), 3.97 (d, J = 12.7 Hz, 1H), 4.43 (dd, J = 12.2, 7.0 Hz, 1H), 4.98–5.06 (m, 1H), c.a. 5.20 (m, 1H), c.a. 5.28 (m, 1H), 5.76 (ddd, J = 17.4, 10.1, 6.8 Hz, 1H). 13C NMR (CD2Cl2, 125 MHz): δ 23.5, 24.5, 37.8, 38.7, 38.8, 41.8, 43.0, 66.6, 72.1, 78.8, 118.2, 134.3. One carbon signal arising from the minor diastereomer was not observable. LRMS (ESI+): [M+H]+ calcd for C13H22N, 192.17; found, 192.15. The relative stereochemistry of the major diastereomer was determined through NOESY analysis (the major diastereomer peaks in the 1H NMR spectrum were assigned and then nOe enhancements were observed).

Cyclohexyl(methyl) pyrrolizidine 2e

In the glovebox, gold precatalyst 7 (3.6 mg, 0.0059 mmol, 10. mol %) was dissolved in 0.1 mL dry DCM and added to a dram vial containing NaBArF salt 8 (5.2 mg, 0.0059 mmol, 10. mol %). Next, 0.1 mL of DCM was used as a rinse to ensure full transfer of the gold precatalyst to the NaBArF vial. The resulting suspension was added to a screw-cap dram vial containing aziridine 1e (13.0 mg, 0.0594 mmol, 1.00 equiv). Then, 0.1 mL of DCM was used as a rinse to ensure full transfer of the (CAAC)AuCl/NaBArF suspension. The resulting solution was added to a screw-cap dram vial containing Pd2dba3 (2.7 mg, 0.0030 mmol, 5.0 mol %). Then, 0.1 mL of DCM was used as a rinse to ensure full transfer of the Pd solution. The solution was transferred to a J. Young tube and 0.2 mL of DCM was used as a rinse to ensure full transfer of the solution. The solution was allowed to run in the J. Young tube at 25 °C for 48 h. The crude reaction mixture was then concentrated in vacuo. The mixture was purified twice, each time using a silica gel pipet column eluting from 1:5:95 NH4OH:MeOH:CHCl3. The product was obtained as a mixture of diastereomers (8.7 mg, 67mol % d.r. = 2.3 : 1.0). Major diastereomer. 1H NMR (CD2Cl2, 500 MHz): δ 1.26 (s, 3H), 1.35–1.71 (m, 12H), 1.82 (d, J = 13.5 Hz, 1H), 1.96 (ddd, J = 12.8, 8.2, 1.2 Hz, 1H), 2.39 (d, J = 9.5 Hz, 1H), 2.69 (dd, J = 11.8, 10.5 Hz, 1H), 2.86–2.93 (m, 1H), 2.92–3.0 (m, 1H), 3.08 (d, J = 9.4 Hz, 1H), 4.95 (ddd, J = 10.2, 1.8, 0.8 Hz, 1H), 5.04 (ddd, J = 17.1, 1.8, 1.1 Hz, 1H), 5.72 (ddd, J = 17.2, 9.9, 7.7 Hz, 1H). Minor diastereomer. 1H NMR (CD2Cl2, 500 MHz): δ 1.20 (s, 3H), 2.40–2.50 (m, 2H), 3.32 (dd, J = 10.6, 8.0 Hz, 1H), 4.92 (ddd, J = 9.3, 1.8, 0.9 Hz, 1H), 5.02 (ddd, J = 17.1, 1.8, 1.2 Hz, 1H), 5.79 (ddd, J = 17.2, 9.9, 7.7 Hz, 1H). Some 1H NMR signals overlapped with the 1H NMR signals of the major diastereomer. 13C NMR (CDCl3, 125 MHz): δ 23.2, 23.5, 24.3, 24.5, 26.3, 26.4, 30.2, 31.4, 36.4, 37.7, 39.0, 39.5, 41.3, 42.9, 45.7, 46.7, 49.1, 52.9, 58.9, 60.9, 66.8, 70.4, 113.9, 114.4, 140.3, 141.4. HRMS (ESI+): [M+H]+ calcd for C15H27N, 220.2065; found, 220.2058. The relative stereochemistry of the major diastereomer was determined through nOe analysis (the major diastereomer peaks in the 1H NMR spectrum were assigned and then the proton at 1.26 ppm was irradiated and the nOe enhancements were observed).

Diphenyl indolizidine 2g

In the glovebox, gold precatalyst 7 (1.5 mg, 0.0025 mmol, 5.0 mol %) was dissolved in 0.1 mL dry DCM and added to a dram vial containing NaBArF salt 8 (2.2 mg, 0.0025 mmol, 5.0 mol %). Next, 0.1 mL of DCM was used as a rinse to ensure full transfer of the gold precatalyst to the NaBArF vial. The resulting suspension was added to a screw-cap dram vial containing aziridine 1g (15.2 mg, 0.0500 mmol, 1.00 equiv). Then, 0.1 mL of DCM was used as a rinse to ensure full transfer of the (CAAC)AuCl/NaBArF suspension. The resulting solution was added to a screw-cap dram vial containing Pd2dba3 (1.1 mg, 0.0013 mmol, 2.5 mol %). Then, 0.1 mL of DCM was used as a rinse to ensure full transfer of the Pd solution. The solution was transferred to a J. Young tube and 0.1 mL of DCM was used as a rinse to ensure full transfer of the solution. The solution was heated in the J. Young tube at 40 °C for 21 h. The crude reaction mixture was then concentrated in vacuo. The mixture was purified four times, each time using a silica gel pipet column eluting from 0.1:0.5:250 NH4OH:MeOH:CH2Cl2. The product was obtained as a mixture of diastereomers (11.3 mg, 74% yield, d.r. = 10 : 1.0). Major diastereomer: 1H NMR (CDCl3, 500 MHz): δ 1.14–1.22 (m, 1H), 1.59–1.67 (m, 2H), 1.71–1.74 (m, 1H), 2.03–2.10 (m, 1H), 2.15 (dt, J = 13.1, 3.5 Hz, 1H), 2.27 (d, J = 11.6 Hz, 1H), 2.51 (dq, J = 13.2, 2.7 Hz, 1H), 2.79–2.89 (m, 1H), 3.25 (t, J = 8.3 Hz, 1H), 3.80 (dd, J = 11.7, 2.1 Hz, 1H), 4.90 (d, J = 10.4 Hz, 1H), 4.98 (d, J = 17.1 Hz, 1H), 5.75–5.83 (m, 1H), 7.14 (t, J = 7.2 Hz, 2H), 7.17–7.28 (m, 7H), 7.43 (d, J = 7.7 Hz, 2H). 13C NMR (CD2Cl2, 125 MHz): δ 28.0, 36.2, 37.7, 40.1, 46.6, 61.0, 62.2, 64.3, 113.2, 125.6, 126.1, 126.8, 128.2, 128.5, 128.9, 142.8, 147.4, 149.7. Minor diastereomer: 1H NMR (CDCl3, 500 MHz): δ 2.21 (d, J = 11.7 Hz, 1H), 2.38 (t, J = 8.6 Hz, 1H), 2.41–c.a. 2.51 (m, 1H), 2.63–2.68 (m, 1H), 2.89 (dd, J = 8.3, 1.8 Hz, 1H), 3.75 (dd, J = 12.0, 2.3 Hz, 1H), 5.87–5.95 (m, 1H). Other peaks overlap with the major diastereomer in the 1H NMR spectrum. HRMS (ESI+): [M+H]+ calcd for C22H26N, 304.2065; found, 304.2060. The relative stereochemistry of the major diastereomer was determined through nOe analysis (the major diastereomer peaks in the 1H NMR spectrum were assigned and then the proton at 2.79–2.98 ppm was irradiated and the nOe enhancements were observed).

Stereochemical investigation of transmetalation reaction of deutero-labeled chiral alkyl gold complex 16

Deuterium-labeled alkyl gold complex 16 was prepared from deuterated amine S-14 according to the method described by Toste.21 The diastereomeric assignment described in the literature characterization was independently confirmed through nOe analysis.

In the glovebox, 2,2'-bipyridine (1.2 mg, 0.0080 mmol, 1.0 equiv) was dissolved in 0.2 mL CD2Cl2 and transferred to a dram vial containing [Pd(MeCN)4][BF4]2 (4.9 mg, 0.0080 mmol, 1.0 equiv). The resulting yellow slurry was added to a dram vial containing alkyl gold complex 16 (6.4 mg, 0.0080 mmol, 1.0 equiv; 2:1 mixture of diastereomers at the deuterated position) using 0.3 mL CD2Cl2 as a rinse. The homogeneous reaction mixture was transferred to a J. Young tube for observation. Starting alkylgold complex 16 was slowly consumed over 16 h, and the sparingly soluble complex [Pd(MeCN)4][BF4]2 entered solution as it reacted. After 16 h, all 16 had been consumed. In the glovebox, the brown, heterogeneous reaction mixture was filtered through a fiberglass pipet filter, and the NMR tube and filter were rinsed with dry DCM (2 × 1 mL) to ensure full transfer. The resulting brown solution was concentrated in vacuo. Further removal of volatiles under reduced pressure (< 10 mTorr) afforded a brown oily residue, which was removed from the glovebox for further purification. The sample was diluted with 0.5 mL DCM, and the addition of 1 mL Et2O resulted in the formation of a dark brown precipitate, which was removed by filtration. The yellow filtrate was concentrated in vacuo to an oily yellow residue and diluted with a minimum of THF and loaded onto an Alltech 600 mg C18 silica Luer-Lok silica cartridge. Elution with THF into 0.2 mL fractions afforded 17 as a mixture with a coproduct containing the Ph3PAu(I) fragment. The reaction was repeated on a larger scale (10×), but no further purification by precipitation or chromatography was possible. Spectroscopic characterization data were obtained from the mixture, with data for the major pyrrolidine product as follows. 1H NMR (CD2Cl2, 500 MHz): δ c.a. 1.23 (0.66 H), 1.34 (s, 9H), 2.32 (dd, J = 12.2, 9.1 Hz, 1H), 2.79 (ddd, J = 12.2, 6.2, 2.1 Hz, 1H), c.a. 3.48–3.52 (1H), 3.53 (d, J = 10.8 Hz, 1H), 4.51 (d, J = 11.0 Hz, 1H), complex overlapping peaks in the aromatic region. Note: The signals near 1.23 ppm, near 3.50, and in the aryl region are partially obfuscated. The minor deuterium diastereomer (0.33 H, arising from transmetalation of the minor diastereomer of deuterated alkylgold complex 16) was not observable by 1H or HSQC NMR spectroscopy, presumably because this signal overlaps with another peak. 13C NMR (CD2Cl2, 125 MHz): δ 20.1, 29.0, 46.9, 51.9, 56.3, complex aromatic region. Two-dimensional NMR techqniques (COSY and HSQC, see Section VI) were instrumental in determining which 1H and 13C signals arose from the transmetalation product 16. HRMS (ESI+): [M]+ calcd for C32H34DN4OPd, 598.1921; found, 598.1902. The observed isotope pattern matches the simulated pattern for 17.

Control experiments

All control experiments were conducted according to the following general procedure, omitting one or more reagents as specified in Table 2 in the manuscript text. In the glovebox, into separate screw-cap dram vials were weighed vinyl aziridine 1a (11.6 mg, 0.0400 mmol, 1.00 equiv), gold precatalyst 7 (1.2 mg, 0.0020 mmol, 5.0 mol %), NaBArF (8, 1.8 mg, 0.0020 mmol, 5.0 mol %), and Pd2dba3 (0.9 mg, 0.001 mmol, 2.5 mol %). Mesitylene (5.6 µL, 0.040 mmol, 1.0 equiv) was added to the vial containing aziridine 1a, and the resulting mixture was dissolved in 0.2 mL CD2Cl2 and transferred successively to the dram vials containing gold precatalyst 7, BArF salt 8, and Pd2dba3 in that order. Each vial was rinsed successively with one 0.2 mL portion of CD2Cl2, and the reaction vessel was capped and allowed to sit in the glovebox for the indicated period of time. The crude reaction was then removed from the glovebox and transferred to an NMR tube for analysis.

Supplementary Material

1_si_001

Acknowledgements

We thank for funding the NSF via a CAREER award (CHE-0748312) to S.A.B, the NIH (1R01GM098512-01A1), and the NSF for a Graduate Fellowship to J.J.H (NSF-201015893). We also thank the NSF for a grant supporting the UCI computational cluster (CHE-0840513). DFT calculations were performed with the assistance of Dr. Nathan R. M. Crawford. We also thank the University of California, Irvine for a Regents Dissertation Fellowship for Y. S. and for additional funding, as well as Mr. Michael D. Garrison and Ms. Eva M. Hahn for assistance with substrate synthesis.

Footnotes

Supporting Information. Full experimental details, characterization data for all new compounds, and computational parameters. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Sammis GM, Danjo H, Jacobsen EN. J. Am. Chem. Soc. 2004;126:9928. doi: 10.1021/ja046653n. [DOI] [PubMed] [Google Scholar]
  • 2.Allen AE, MacMillan DWC. Chem. Sci. 2012;3:633. doi: 10.1039/C2SC00907B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shi Y, Roth KE, Ramgren SD, Blum SA. J. Am. Chem. Soc. 2009;131:18022. doi: 10.1021/ja9068497. [DOI] [PubMed] [Google Scholar]
  • 4.Shi Y, Peterson SM, Haberaecker WW, III, Blum SA. J. Am. Chem. Soc. 2008;130:2168. doi: 10.1021/ja710648b. [DOI] [PubMed] [Google Scholar]
  • 5.Jacobsen EN. Acc. Chem. Res. 2000;33:421. doi: 10.1021/ar960061v. [DOI] [PubMed] [Google Scholar]
  • 6.Liu Z, Henderson JA, Sasaki T, Kishi Y. J. Am. Chem. Soc. 2009;131:16678. doi: 10.1021/ja9079308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.(a) Trost BM, Luan X. J. Am. Chem. Soc. 2011;133:1706. doi: 10.1021/ja110501v. [DOI] [PubMed] [Google Scholar]; (b) Trost BM, Luan X, Miller Y. J. Am. Chem. Soc. 2011;133:12824. doi: 10.1021/ja204817y. [DOI] [PubMed] [Google Scholar]
  • 8.(a) Wu H, He YP, Gong LZ. Adv. Synth. Catal. 2012;354:975. [Google Scholar]; (b) Weber D, Gagné MR. Chem. Commun. 2011;47:5172. doi: 10.1039/c1cc11055a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.(a) Nakao Y, Yada A, Ebata S, Hiyama T. J. Am. Chem. Soc. 2007;129:2428. doi: 10.1021/ja067364x. [DOI] [PubMed] [Google Scholar]; (b) Koester DC, Kobayashi M, Werz DB, Nakao Y. J. Am. Chem. Soc. 2012;134:6547. doi: 10.1021/ja301375c. [DOI] [PubMed] [Google Scholar]
  • 10.Graham TJA, Shields JD, Doyle AG. Chem. Sci. 2011;2:980. [Google Scholar]
  • 11.Nicewicz DA, MacMillan DWC. Science. 2008;322:77. doi: 10.1126/science.1161976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Skucas E, MacMillan DWC. J. Am. Chem. Soc. 2012;134:9090. doi: 10.1021/ja303116v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.DiRocco DA, Rovis T. J. Am. Chem. Soc. 2012;134:8094. doi: 10.1021/ja3030164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Burns NZ, Written MR, Jacobsen EN. J. Am. Chem. Soc. 2011;133:14578. doi: 10.1021/ja206997e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hashmi ASK. Chem. Rev. 2007;107:3180. doi: 10.1021/cr000436x. [DOI] [PubMed] [Google Scholar]
  • 16.Li Z, Brouwer C, He C. Chem. Rev. 2008;108:3239. doi: 10.1021/cr068434l. [DOI] [PubMed] [Google Scholar]
  • 17.Gorin DJ, Sherry BD, Toste FD. Chem. Rev. 2008;108:3351. doi: 10.1021/cr068430g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hirner JJ, Shi Y, Blum SA. Acc. Chem. Res. 2011;44:603. doi: 10.1021/ar200055y. [DOI] [PubMed] [Google Scholar]
  • 19.Shi Y, Ramgren SD, Blum SA. J. Am. Chem. Soc. 2009;28:1275. doi: 10.1021/ja9068497. [DOI] [PubMed] [Google Scholar]
  • 20.(a) Zhang J, Yang CG, He C. J. Am. Chem. Soc. 2006;128:1798. doi: 10.1021/ja053864z. [DOI] [PubMed] [Google Scholar]; (b) Bender CF, Widenhoefer RA. Chem. Commun. 2008:2741. doi: 10.1039/b804081h. [DOI] [PubMed] [Google Scholar]
  • 21.LaLonde RL, Brenzovich WE, Jr, Benitez D, Tkatchouk E, Kelley K, Goddard WA, III, Toste FD. Chem. Sci. 2010;1:226. doi: 10.1039/C0SC00255K. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Some reports have suggested the metal is active only in forming a Brøsted acid that is responsible for protonation of the olefin. See (a) ref. 21. Kanno O, Kuriyama W, Wang ZJ, Toste FD. Angew. Chem. Int. Ed. 2011;50:9919. doi: 10.1002/anie.201104076. Rosenfeld DC, Shekhar S, Takemiya A, Utsunomiya M, Hartwig JF. Org. Lett. 2006;8:4179. doi: 10.1021/ol061174+. McBee JL, Bell AT, Tilley TD. J. Am. Chem. Soc. 2008;130:16562. doi: 10.1021/ja8030104..
  • 23.Gong recently reported a sequentially catalyzed carboamination of alkynes to form pyrrolidines, in a stepwise system that relies on Au-catalyzed formation of an enamine and then separate subsequent Pd-catalyzed allyl transfer. See ref. 8.
  • 24.Zeng X, Kinjo R, Donnadieu B, Bertrand G. Angew. Chem. Int. Ed. 2010;49:942. doi: 10.1002/anie.200905341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Amatore C, Jutland A, Mensah L, Meyer G, Fiaud JC, Legros J-Y. Eur. J. Org. Chem. 2006:1185. [Google Scholar]
  • 26.Mattocks AR. Nature. 1968;217:723. doi: 10.1038/217723a0. [DOI] [PubMed] [Google Scholar]
  • 27.Kim HY, Stermitz FR, Molyneux RJ, Wilson DW, Taylor D, Coulombe RA., Jr Toxicol. Appl. Pharmacol. 1993;122:61. doi: 10.1006/taap.1993.1172. [DOI] [PubMed] [Google Scholar]
  • 28.Liddell JR. Nat. Prod. Rep. 2002;19:773. doi: 10.1039/b108975g. [DOI] [PubMed] [Google Scholar]
  • 29.Spasov AA, Khamidova TV, Bugaeva LI, Morozov IS. Pharm. Chem. J. 2000;34:1. [PubMed] [Google Scholar]
  • 30.Lorenz I-P, Krinninger C, Wilberger R, Bobka R, Piotrowski H, Warchhold M, Nöth H. J. Organomet. Chem. 2005;690:1986. [Google Scholar]
  • 31.Yamamoto Y. J. Org. Chem. 2007;72:7817. doi: 10.1021/jo070579k. [DOI] [PubMed] [Google Scholar]
  • 32.For a proposed activation by bidentate binding of Au(I) simultaneously to an alkyne and an aziridine, see: Kern N, Blanc A, Miaskiewicz S, Robinette M, Weibel JM, Pale P. J. Org. Chem. 2012;77:4323. doi: 10.1021/jo300294r..
  • 33.Jung ME, Piizii G. Chem. Rev. 2005;105:1735. doi: 10.1021/cr940337h. [DOI] [PubMed] [Google Scholar]
  • 34.Shapiro ND, Toste FD. Proc. Natl. Acad. Sci. USA. 2008;105:2779. [Google Scholar]
  • 35.For selected references proposing anti aminoauration reactions, see: Hashmi ASK, Rudolph M, Schymura S, Visus J, Frey W. Euro. J. Org. Chem. 2006;21:4905. Iglesias A, Muñz K. Chem. Eur. J. 2009;15:10563. Zhang G, Cui L, Wang Y, Zhang L. J. Am. Chem. Soc. 2010;132:1474. doi: 10.1021/ja909555d. Li H, Song F, Widenhoefer RA. Adv. Synth. Catal. 2011;353:955. doi: 10.1002/adsc.201000844. de Haro T, Nevado C. Angew. Chem. Int. Ed. 2011;50:906. doi: 10.1002/anie.201005763..
  • 36.Tkatchouk E, Mankad NP, Benitez D, Goddard WA, III, Toste FD. J. Am. Chem. Soc. 2011;133:14293. doi: 10.1021/ja2012627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.(a) Shi Y, Ramgren SD, Blum SA. Organometallics. 2009;28:1705. [Google Scholar]; (b) Peñ-López M, Ayá-Varela M, Sarandeses LA, Péez Sestelo J. Chem.— Eur. J. 2010;16:9905. doi: 10.1002/chem.201000726. [DOI] [PubMed] [Google Scholar]
  • 38.(a) Ridgway BH, Woerpel KA. J. Org. Chem. 1998;63:458. doi: 10.1021/jo970803d. [DOI] [PubMed] [Google Scholar]; (b) Taylor BLH, Jarvo ER. J. Org. Chem. 2011;76:7573. doi: 10.1021/jo201263r. [DOI] [PubMed] [Google Scholar]
  • 39.Imao D, Glasspoole BW, Laberge VS, Crudden CM. J. Am. Chem. Soc. 2009;131:5204. doi: 10.1021/ja8094075. [DOI] [PubMed] [Google Scholar]
  • 40.Bäkvall JE, Åermark B. J. Chem. Soc. Chem. Commun. 1975:82. [Google Scholar]
  • 41.As evidenced by its resistance to protonolysis. See: Roth KE, Blum SA. Organometallics. 2010;29:1712..
  • 42.Milstein D, Stille JK. J. Am. Chem. Soc. 1979;101:4981. [Google Scholar]
  • 43.Alkyl Grignard reagents are thought to undergo transmetalation through a racemizing single-electron transfer pathway. See Dakternieks D, Dunn K, Henry DJ. Organometallics. 1999;18:3342. Hoffmann RW, Hözer B. J. Am. Chem. Soc. 2002;124:4204. doi: 10.1021/ja025638k..
  • 44.Klein S, Marek I, Normant JF. J. Org. Chem. 1994;59:2925. [Google Scholar]
  • 45.Sandrock DL, Jean-Géard L, Chen C-Y, Dreher SD, Molander GA. J. Am. Chem. Soc. 2010;132:17108. doi: 10.1021/ja108949w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Benzylic siliconates are known to undergo transmetalation to Pd with either inversion or retention depending upon the solvent and temperature at which the reaction is conducted. Inversion was only observed in HMPU and is proposed to occur through an SE2-type pathway. See: Hatanaka Y, Hiyama T. J. Am. Chem. Soc. 1990;112:7793..
  • 47.Nonpolarized benzylic trialkylstannanes have been shown to undergo exclusively invertive benzyl transfer to Pd, but this reaction occurs in HMPA and is thought to occur thorugh an SE2 mechanism. See: Labadie JW, Stille JK. J. Am. Chem. Soc. 1983;105:669..
  • 48.Of particular relevance to this mechanistic hypothesis is Trost’s application of Pd(0) catalysis in preparation of a number of heterocycles from vinyl aziridines, although in the absence of a Lewis acid. For two representative examples, see: Trost BM, Fandrick DR. J. Am. Chem. Soc. 2003;125:11836. doi: 10.1021/ja037450m. Trost BM, Osipov M, Dong G. J. Am. Chem. Soc. 2010;132:1580. doi: 10.1021/ja1071509..
  • 49.Toste and coworkers originally proposed a syn aminoauration reaction as a part of a Au(I)/Au(III) catalytic cycle, but they have since published a revised mechanism. See ref. 36 for the revision. For the original hypothesis, see: Bernzovich WE, Jr, Benitez D, Lackner AD, Shunatona HP, Tkatchouk E, Goddard WA, III, Toste FD. Angew. Chem. Int. Ed. 2010;49:5519. doi: 10.1002/anie.201002739..
  • 50.As a related process, we have found a single example of a hypothesized syn alkoxyauration with under Au(I)-catalyzed conditions. However, this reaction occurs in the presence of 0.99 equiv concentrated H2SO4 and is therefore not directly related to most other Au-catalyzed processes. See: Teles JH, Brode S, Chabanas M. Angew. Chem. Int. Ed. 1998;37:1415. doi: 10.1002/(SICI)1521-3773(19980605)37:10<1415::AID-ANIE1415>3.0.CO;2-N..
  • 51.See the commentary provided in: Hopkinson MN, Gee AD, Gouverneur V. Chem. Eur. J. 2011;17:8248. doi: 10.1002/chem.201100736..
  • 52.Hesp KD, Stradiotto M. J. Am. Chem. Soc. 2010;132:18026. doi: 10.1021/ja109192w. [DOI] [PubMed] [Google Scholar]
  • 53.Hanley PS, Marković D, Hartwig JF. J. Am. Chem. Soc. 2010;132:6302. doi: 10.1021/ja102172m. [DOI] [PubMed] [Google Scholar]
  • 54.For reviews containing information regarding this elementary step and its application to the synthesis of heterocycles, see: Schultz DM, Wolfe JP. Synthesis. 2012;44:351. doi: 10.1055/s-0031-1289668. Minatti A, Muñiz K. Chem. Soc. Rev. 2007;36:1142. doi: 10.1039/b607474j..
  • 55.(a) Bertrand MB, Wolfe JP. Org. Lett. 2007;9:3073. doi: 10.1021/ol071120f. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Neukom JD, Perch NS, Wolfe JP. J. Am. Chem. Soc. 2010;132:6276. doi: 10.1021/ja9102259. [DOI] [PubMed] [Google Scholar]; (c) Neukom JD, Perch NS, Wolfe JP. Organometallics. 2011;30:1269. [Google Scholar]
  • 56.Perdew JP, Burke K, Ernzerhof M. Phys. Rev. Lett. 1996;77:3865. doi: 10.1103/PhysRevLett.77.3865. [DOI] [PubMed] [Google Scholar]
  • 57.Serra D, Moret ME, Chen P. J. Am. Chem. Soc. 2011;133:8914. doi: 10.1021/ja110405q. [DOI] [PubMed] [Google Scholar]
  • 58.We cannot rule out the possibility that the reduced product yield is due to loss of a portion of the gold catalyst during filtration.
  • 59.Evans LA, Fey N, Harvey JN, Hose D, Lloyd-Jones GC, Murray P, Orpen AG, Osborne R, Owen-Smith GJJ, Purdie M. J. Am. Chem. Soc. 2008;130:14471. doi: 10.1021/ja806278e. [DOI] [PubMed] [Google Scholar]
  • 60.The data presently available are also consistent with a syn addition of the Lewis acid/amide σ-bond of 14 across the tethered olefin followed by transmetalation to the Pd π-allyl cation, but we suspect the trapping of the Pd electrophile may be a much faster pathway. For one related example of syn addition of Li- and Na-amides across olefins, see: Ates A, Quinet C. Eur. J. Org. Chem. 2003:1623..
  • 61.Lavallo V, Frey GD, Kousar S, Donnadieu B, Bertrand G. Proc. Natl. Acad. Sci. USA. 2007;104:13569. doi: 10.1073/pnas.0705809104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Yakelis NA, Bergman RG. Organometallics. 2005;24:3579. doi: 10.1021/om0501428. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES